Clinical Trial

A Study to Evaluate the Safety, PK, and Immunogenicity of Recombinant Human Hyaluronidase in Healthy Subjects

Name: A Study to Evaluate the Safety, PK, and Immunogenicity of Recombinant Human Hyaluronidase in Healthy Subjects — clinical trial record (NCT07484893)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The study is being conducted to evaluate the safety, pharmacokinetics, and immunogenicity of recombinant human hyaluronidase in healthy Chinese adult male subjects.

Trial Details

NCT Number	NCT07484893
Lead Sponsor	Shanghai Henlius Biotech
Conditions	Healthy Adult Male
Enrollment	24 participants
Start Date	2026-05-14
Primary Completion	2026-08-25 (estimated)
Study Completion	2026-10-24 (estimated)
Updated on ClinicalTrials.gov	2026-03-20